Apyx Medical Corp

APYX
As of the close on Sep 25, 2026
Price
$2.96
Market cap
—
The latest share count on file is too old
P/E (diluted TTM)
—
Per-share earnings are not available for each of the last four quarters
EPS (TTM)
—
Per-share earnings are not available for each of the last four quarters
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Apyx Medical Corp Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Apyx Medical Corp — 10-Q filed Aug 6, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 16 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 17, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
TRUST CO OF TOLEDO NA /OH/ 2026-03-31 1,000 $3.69K SEC filing
Diametric Capital, LP 2026-03-31 12,833 $47.4K SEC filing
Engineers Gate Manager LP 2026-03-31 15,340 $56.6K SEC filing
SEI INVESTMENTS CO 2026-03-31 598,255 $2.21M SEC filing
Tower Research Capital LLC (TRC) 2026-03-31 652 $2.41K SEC filing
BlackRock, Inc. 2026-03-31 527,748 $1.95M SEC filing
OMERS ADMINISTRATION Corp 2026-03-31 12,000 $44.3K SEC filing
Nantahala Capital Management, LLC 2026-03-31 3,440,304 $12.7M SEC filing
GEODE CAPITAL MANAGEMENT, LLC 2026-03-31 391,356 $1.45M SEC filing
Legato Capital Management LLC 2026-03-31 280,889 $1.04M SEC filing
ROYAL BANK OF CANADA 2026-03-31 4,821 $18K SEC filing
XTX Topco Ltd 2026-03-31 23,097 $85.2K SEC filing
Hudson Bay Capital Management LP 2026-03-31 54,001 $199K SEC filing
ROYCE & ASSOCIATES LP 2026-03-31 2,611,224 $9.64M SEC filing
Caption Management, LLC 2026-03-31 185,751 $685K SEC filing
Catalyst Funds Management Pty Ltd 2026-03-31 24,072 $88.8K SEC filing
Point72 Asset Management, L.P. 2026-03-31 34,778 $128K SEC filing
HORIZON KINETICS ASSET MANAGEMENT LLC 2026-03-31 615,000 $2.27M SEC filing
ESSEX INVESTMENT MANAGEMENT CO LLC 2026-03-31 901,398 $3.33M SEC filing
  • Each value is checked against Apyx Medical Corp's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • 1 row left out: the value per share it reports is far from Apyx Medical Corp's share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.

Filer report history

Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security. Filers with a row left out above, or with no row above to check, are not listed.

  • HORIZON KINETICS ASSET MANAGEMENT LLC: 615,000 shares reported 2025-12-31; 615,000 shares reported 2026-03-31.
  • Point72 Asset Management, L.P.: 22,187 shares reported 2025-12-31; 34,778 shares reported 2026-03-31.
  • Caption Management, LLC: 160,407 shares reported 2025-12-31; 185,751 shares reported 2026-03-31.
  • ROYCE & ASSOCIATES LP: 2,443,035 shares reported 2025-12-31; 2,611,224 shares reported 2026-03-31.
  • Hudson Bay Capital Management LP: 20,719 shares reported 2025-12-31; 54,001 shares reported 2026-03-31.
  • ROYAL BANK OF CANADA: 3,994 shares reported 2025-12-31; 4,821 shares reported 2026-03-31.
  • GEODE CAPITAL MANAGEMENT, LLC: 358,829 shares reported 2025-12-31; 391,356 shares reported 2026-03-31.
  • Nantahala Capital Management, LLC: 3,974,091 shares reported 2025-12-31; 3,440,304 shares reported 2026-03-31.
  • OMERS ADMINISTRATION Corp: 31,722 shares reported 2025-12-31; 12,000 shares reported 2026-03-31.
  • BlackRock, Inc.: 510,980 shares reported 2025-12-31; 527,748 shares reported 2026-03-31.
  • Tower Research Capital LLC (TRC): 1,458 shares reported 2025-12-31; 652 shares reported 2026-03-31.
  • SEI INVESTMENTS CO: 150,081 shares reported 2025-12-31; 598,255 shares reported 2026-03-31.

Showing the 12 most recent filer reports.

24 filers have only one report here.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Apyx Medical Corp's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

  • 2009-05-26 · MAKRIDES ANDREW: Larger than 16 of the 17 other insider sales of Common stock on file. SEC filing
  • 2009-05-21 · MAKRIDES ANDREW: Larger than all 17 other insider sales of Common stock on file. SEC filing

Independent insiders buying near the same time

  • 2015-12-21–2015-12-22: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )

Purchases & sales (open market or private)

SecurityCodePriceFiling
2024-08-13 (amended)HILL MATTHEW C · Chief Financial OfficerCommon StockP — Open market or private purchase+6,0001.13SEC filing
2024-08-13HILL MATTHEW C · Chief Financial OfficerCommon StockP — Open market or private purchase+5,3361.13SEC filing
2023-12-12HILL MATTHEW C · Chief Financial OfficerCommon StockP — Open market or private purchase+2,5002.19SEC filing
2023-11-14Goodwin Charles D. II · Chief Executive OfficerCommon StockP — Open market or private purchase+50,0001.57SEC filing
2023-06-26 (amended)Hornsby Todd · Executive Vice PresidentCommon StockS — Open market or private sale−15,0007.56SEC filing
2022-08-29Goodwin Charles D. II · Chief Executive OfficerCommon StockP — Open market or private purchase+2,0005.93SEC filing
2022-08-29Goodwin Charles D. II · Chief Executive OfficerCommon StockP — Open market or private purchase+9,7505.97SEC filing
2020-05-13Goodwin Charles D. II · Chief Executive OfficerCommon StockP — Open market or private purchase+28,2503.30SEC filing

Showing 8 of 20 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-06-15Roman Shawn David · Chief Operating OfficerCommon StockM — Exercise or conversion of derivative security+15,000SEC filing
2026-06-15Roman Shawn David · Chief Operating OfficerStock option (right to buy)M — Exercise or conversion of derivative security−15,000SEC filing
2026-06-15Roman Shawn David · Chief Operating OfficerCommon StockF — Payment of exercise price or tax by delivering securities−10,533SEC filing
2026-06-11Vizirgianakis Stavros G. · DirectorRestricted Stock UnitsA — Grant, award, or other acquisition+450,000SEC filing
2026-06-11Baylor-Henry Minnie · DirectorStock Option (Option to Buy)A — Grant, award, or other acquisition+50,000SEC filing
2026-06-11Goodwin Charles D. II · Chief Executive OfficerStock Option (Option to Buy)A — Grant, award, or other acquisition+213,948SEC filing
2026-06-11CITRONOWICZ MOSHE · Sr. V.P. of OperationsStock Option (Option to Buy)A — Grant, award, or other acquisition+63,392SEC filing
2026-06-11Roman Shawn David · Chief Operating OfficerStock Option (Option to Buy)A — Grant, award, or other acquisition+88,044SEC filing

Showing 8 of 29 rows

Other activity

SecurityCodeFiling
2015-03-17Sheffield Ian · DirectorCommon Stock Warrants (right to buy)D — Disposition to the issuer+5,250,000SEC filing
2015-03-17Sheffield Ian · DirectorSeries A Convertible Preferred StockD — Disposition to the issuer+3,500,000SEC filing
2011-11-29CITRONOWICZ MOSHE · OtherStock optionsJ — Other acquisition or disposition−25,000SEC filing
2011-11-29CITRONOWICZ MOSHE · OtherStock optionJ — Other acquisition or disposition−25,000SEC filing

Showing 4 of 4 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.